Alnylam Pharmaceuticals · 1 day ago
Senior Manager Program Management
Cambridge, MA
Full-time
Hybrid
Mid, Senior Level
3+ years expAlnylam Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing transformative medicines. The Senior Manager, Program Management will partner with Program Leaders to drive program strategy and execution, ensuring effective coordination across cross-functional teams.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Hiring Manager
Adam Lentz, MBA
Responsibilities
Partner closely with Program Leaders to shape and execute the Program strategy, goals and plans and ensure alignment within the Program Team and across all expertise areas
Lead development and drive execution of Program workplans/timelines and integrated development plans with milestones/goals, key events, risks/assumptions, and scenarios
Lead high-performing teams while driving coordination of cross-functional activities and promote effective communications (e.g., Team meetings, program updates); integration of people involved within the program (e.g. clarity of responsibilities)
In partnership with the Program Leader, ensure clear, timely, and substantive updates on Program progress and issues to Senior Leadership
Manage Program Leadership Team meetings, including leading discussions to drive to decision-making, agenda creation, meeting minutes, and actions
Serve as a key point person for Leadership Team members and governance teams
Owner of key program documents, e.g., integrated development plan, risk plan, and additional key status and timeline updates, ensure team members have easy access to program information
Partner with finance on all financial aspects of the Program
Provide insights on program management initiatives including alignment of processes, tools, and technologies that aid in portfolio management across the organization
Qualification
Required
Bachelor's degree or higher-level education in sciences or related field required
Minimum of 3-5 years experience in biotechnology or pharmaceutical industry with an in depth knowledge of drug development demonstrated experience working with and managing cross-functional program teams
Direct drug development program management experience, with ability to work in early and/or late-stage clinical programs
Demonstrated ability to work proactively, both independently and collaboratively, in a dynamic team environment, set priorities and drive to results; ability to integrate multiple viewpoints and build alignment
Ability to understand interdependencies and critical path across drug development
Excellent written and oral communication, including presentation, facilitation skills and a strong presence when speaking
Strong analytical and problem-solving skills; ability to combine attention to detail within broader strategic context
Superior collaboration and negotiation skills, and high degree of self-awareness
Ability to thrive in a fast-paced environment with strong ability to simultaneously handle multiple activities, with agility and adaptability
Proficiency with program/project management tools such as PowerPoint, Word, Excel, and/or Smartsheets or similar
Passion for helping patients and developing transformative treatments for patients in need; motivated by patient focus and personal commitment to high performance and results
Preferred
Advanced degree in a scientific discipline preferred
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
2025-12-22
2025-12-20
Company data provided by crunchbase